Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece, on Blood Gases and Respiratory Rate, in ICU Tracheostomized Patients

January 9, 2018 updated by: Konstantinos Grigoriadis, Attikon Hospital

Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece on Blood Gases and Respiratory Rate in ICU Tracheostomized Patients as an Extra Supporting Method During Weaning From Mechanical Ventilation.

The study investigates if there are benefits (better oxygenation, minimized work of breath) from the parallel oxygenation with Tracheal Gas Insufflation and T-piece, in order to provide respiratory support in tracheostomized patients and avoid mechanical ventilation.

Study Overview

Detailed Description

The tracheal insufflation (TGI) of respiratory gasses near to carina is a technique who designed for the removement of exhaled carbon dioxide from the dead space of the lung. In order to investigate the utility of this technique on weaning of mechanical ventilation 11 tracheostomized patients on T-piece were recruited, with stable blood gasses more than 24 hours.

A TGI catheter enters the trachea through a new opened hole on the top of T-piece and then passes through the tracheostomy tube to inside of the trachea and then stops one centimeter before the carina. Patients received two parallel administered respiratory gases with the same fraction of inspired oxygen (FiO2), through a T-piece and an endotracheal catheter, with flows 6 Liters Per Minute (L/min) and 11 L/min, while continuously monitored by impedance tomography device (ΕΙΤ). ΕΙΤ is a noninvasive imaging technique for monitoring in real time the lung volumes and the regional lung ventilation without ionizing radiation.

The basic hypothesis of the study is if there are benefits (better oxygenation, minimized work of breath) from the parallel oxygenation with Tracheal Gas Insufflation and T-piece, in order to provide respiratory support in tracheostomized patients and avoid mechanical ventilation.

The randomization of the study was achieved using sealed envelopes method and associated with the flow to be first (6L/min or 11L/min) via Tracheal Gas Insufflation Catheter (6 envelopes with the inscription 6 L/min on the inner side and 6 envelopes with the inscription 6 L/min on the inner side 11 L/min)

Τhe investigators tested the differences on partial pressure of oxygen (PaO2), respiratory rate and end expiratory impedance:

  1. Before gasses supply via TGI
  2. During 6L/min
  3. During 11L/min
  4. And finally with no gasses supply via TGI

Additionally the following were monitored:

  • Heart rate
  • Systolic and diastolic blood pressure
  • Oxygen saturation as disturbing factors and,
  • potential of hydrogen (pH)
  • PaCO2
  • hydrogen carbonate (-HCO3) for the monitoring of the acid-base balance of the patient during procedure.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Attica
      • Athens, Attica, Greece, 12462
        • Attikon University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 84 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Tracheostomized haemodynamically stable patients, without the need of vasopressors or inotrope medications, without symptoms of pulmonary edema, or interstitial lung diseases.

Stable blood gasses (no bigger changes than 15-20% in Oxygen and Carbon dioxide during last 24 hours)

Exclusion Criteria:

  • Peripheral body temperature < 38 C, White blood cells (WBCs) < 15 x 109/L
  • Respiratory rate >35
  • Paradoxical breathing
  • Abdominal muscle recruitment
  • Dyspnoea, SaO2 < 94, without evidence of angina, cyanosis or arrhythmia.
  • Chest circumferences no bigger than 110 cm (for the larger belt of impedance tomograph)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TGI 6 L/min
Tracheal gas insufflation 6 L/min
Endotracheal flow (6 L/min) of respiratory gases with standard FiO2
Active Comparator: TGI 11 L/min
Tracheal gas insufflation 11 L/min
Endotracheal flow (11 L/min) of respiratory gases with standard FiO2
Active Comparator: TGI 0 L/min
Tracheal gas insufflation catheter, without gas flow
Tracheal gas insufflation catheter, without gas flow

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Rate
Time Frame: 60 minutes
Respiratory cycles per minute at flows: 0, 6, 11, 0 L/min
60 minutes
partial pressure of oxygen (PaO2)
Time Frame: 60 minutes
Arterial blood oxygen tension at flows: 0, 6, 11,0 L/min
60 minutes
End respiratory lung impedance differences
Time Frame: 60 minutes
End respiratory lung impedance differences at flows: 0, 6, 11, 0 L/min
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: 60 minutes
Heart beats per minute at flows: 0, 6, 11, 0 L/min
60 minutes
Systolic blood pressure
Time Frame: 60 minutes
Systolic blood pressure (mmHg) at flows: 0, 6, 11, 0 L/min
60 minutes
Diastolic blood pressure
Time Frame: 60 minutes
Diastolic blood pressure (mmHg) at flows: 0, 6, 11, 0 L/min
60 minutes
Oxygen saturation (SaO2)
Time Frame: 60 minutes
Oxygen saturation (%) at flows: 0, 6, 11, 0 L/min
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Konstantinos E Grigoriadis, Pt, MSc, National and Kapodistrian University of Athens
  • Study Chair: Iraklis Tsagaris, MD. PhD, National and Kapodistrian University of Athens
  • Study Chair: Antonia D Koutsoukou, MD, PhD, National and Kapodistrian University of Athens
  • Study Chair: Eirini P Grammatopoulou, PT, PhD, Technological Educational Institution of Athens
  • Study Chair: Anna K Grigoriadou, PT, Lamia University of Applied Sciences
  • Study Director: Apostolos E Armaganidis, National and Kapodistrian University of Athens

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

January 27, 2017

First Submitted That Met QC Criteria

February 1, 2017

First Posted (Estimate)

February 2, 2017

Study Record Updates

Last Update Posted (Actual)

January 10, 2018

Last Update Submitted That Met QC Criteria

January 9, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resp Gas Exchange Disorder Nos

Clinical Trials on Tracheal gas insufflation 6 L/min

3
Subscribe